Yoshitaka Miyakawa Selected Research

Yoshitaka Miyakawa Research Topics

Disease

12	Neoplasms (Cancer) 01/2021 - 07/2003
11	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2023 - 10/2008
9	Thrombotic Thrombocytopenic Purpura 11/2023 - 01/2016
8	Thrombocytopenia (Thrombopenia) 11/2023 - 08/2008
8	Atypical Hemolytic Uremic Syndrome 06/2021 - 01/2017
6	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 03/2024 - 01/2021
6	Thrombotic Microangiopathies 06/2021 - 01/2017
4	Hemorrhage 11/2023 - 01/2014
4	Fatigue 10/2023 - 01/2021
4	Anemia 01/2023 - 12/2007
4	Hemolysis 01/2023 - 02/2017
4	Multiple Myeloma 01/2014 - 07/2004
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2004 - 07/2003
3	Hemolytic Anemia 11/2023 - 07/2017
3	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 01/2015
3	Leukemia 02/2004 - 01/2003
2	Chronic Disease (Chronic Diseases) 10/2023 - 10/2022
2	Respiratory Insufficiency (Respiratory Failure) 02/2022 - 01/2014
2	Acute Kidney Injury (Acute Renal Failure) 06/2021 - 01/2009
2	Infections 02/2017 - 08/2011
2	Lymphoma (Lymphomas) 06/2015 - 01/2005
2	Essential Thrombocythemia 10/2014 - 03/2013
2	Cytopenia 01/2011 - 09/2003
2	Hepatocellular Carcinoma (Hepatoma) 08/2008 - 01/2004
2	Hypercalcemia (Milk Alkali Syndrome) 08/2007 - 07/2003
2	Acute Promyelocytic Leukemia 03/2005 - 01/2004
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2003 - 06/2002
1	Connective Tissue Diseases (Connective Tissue Disease) 12/2023
1	Epistaxis (Nosebleed) 03/2023
1	Gastrointestinal Hemorrhage (Hematochezia) 03/2023
1	Purpura 03/2023
1	Pure Red-Cell Aplasia 02/2022
1	COVID-19 02/2022
1	Chronic Renal Insufficiency 06/2021
1	Crohn Disease (Crohn's Disease) 01/2021
1	Enterocolitis 01/2021
1	Fever (Fevers) 01/2020
1	Hemoptysis 04/2019
1	Disease Susceptibility (Diathesis) 04/2019
1	Factor V Deficiency 04/2019
1	Meningococcal Infections 01/2019
1	Sepsis (Septicemia) 02/2017
1	Disseminated Intravascular Coagulation 02/2017
1	Septic Shock (Toxic Shock Syndrome) 02/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2017
1	acquired Thrombotic thrombocytopenic purpura 08/2016
1	Malignant Hypertension 01/2016
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 06/2015
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2015
1	Diarrhea 10/2014
1	Headache (Headaches) 10/2014
1	Empyema 01/2014
1	Collagen Diseases (Collagen Disease) 01/2014

Drug/Important Bio-Agent (IBA)

9	Inosine Triphosphate (ITP)IBA 12/2023 - 08/2011
9	Rituximab (Mabthera)FDA Link 01/2021 - 08/2011
6	sutimlimabIBA 03/2024 - 01/2021
6	thiamine triphosphorate (TTP)IBA 11/2023 - 01/2016
5	Imatinib Mesylate (Gleevec)FDA Link 11/2004 - 08/2002
4	Complement System Proteins (Complement)IBA 12/2023 - 02/2017
4	ravulizumabIBA 06/2021 - 01/2020
4	eculizumab FDA Link 01/2019 - 01/2017
3	Complement C1s (C1 Esterase)IBA 01/2023 - 01/2022
3	Hemoglobins (Hemoglobin)IBA 01/2023 - 03/2004
3	Complement Inactivating AgentsIBA 05/2021 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 01/2014 - 06/2004
3	Thrombopoietin (c-mpl Ligand)IBA 10/2008 - 01/2004
3	SultanIBA 11/2007 - 07/2004
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2005 - 06/2002
2	AutoantibodiesIBA 11/2023 - 12/2015
2	BilirubinIBA 01/2023 - 01/2021
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2022 - 01/2003
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2022 - 04/2019
2	Factor V (Coagulation Factor V)IBA 04/2019 - 01/2014
2	anagrelide (Agrylin)FDA LinkGeneric 10/2014 - 03/2013
2	Immunoglobulins (Immunoglobulin)IBA 09/2013 - 12/2007
2	Thrombopoietin ReceptorsIBA 09/2013 - 08/2011
2	CaspasesIBA 11/2007 - 01/2005
2	Diphosphonates (Bisphosphonates)IBA 08/2007 - 07/2003
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2005 - 01/2004
2	Messenger RNA (mRNA)IBA 07/2004 - 01/2004
1	neonatal Fc receptorIBA 11/2023
1	von Willebrand FactorIBA 03/2023
1	Alanine Transaminase (SGPT)IBA 03/2023
1	caplacizumabIBA 03/2023
1	Complement C5 (Complement 5)IBA 06/2021
1	CreatinineIBA 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020
1	Dacarbazine (DIC)FDA LinkGeneric 02/2017
1	Monoclonal AntibodiesIBA 02/2017
1	Bendamustine Hydrochloride FDA Link 06/2015
1	SteroidsIBA 01/2015
1	romiplostim FDA Link 01/2015
1	Immunoglobulin E (IgE)IBA 01/2014
1	EnzymesIBA 01/2014

Therapy/Procedure

13	Therapeutics 11/2023 - 01/2004
3	Drug Therapy (Chemotherapy) 10/2008 - 08/2002
2	Artificial Respiration (Mechanical Ventilation) 02/2022 - 01/2014
2	Plasma Exchange 01/2019 - 01/2017
2	Splenectomy 01/2015 - 08/2011
1	Blood Transfusion (Blood Transfusions) 02/2022